Cytori (NASDAQ:CYTX) was informed that stem and regenerative cells from a patient's own fat tissue were used to treat stress urinary incontinence (SUI) as part of an investigator-initiated five patient pilot study in Japan. The results, reported at the 7th Annual Meeting of the International Federation for Adipose Therapeutics and Science, suggest that the investigational treatment is safe and feasible. The study was led by Momokazu Gotoh, MD, Ph.D.
Read more...